IFN-γ can regulate the kynurenine pathway, which is activated by indoleamine 2,3-dioxygenase 1 (IDO1) to catabolize tryptophan into kynurenine and exert immunosuppressive effects [25] in both melanoma and normal cells in the skin [26]. The gene discussed is IDO1; the disease is melanoma.